Company: BDRX
Filing Date: 2025-11-17
Form Type: F-1
Source: 0001214659-25-016821
Chunk: 6

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-11-17
Form: F-1
Chunk 6
---
 not be indicative of the final public offering price.

The Units have no stand-alone
rights and will not be certificated or issued as stand-alone securities.

There is no established trading
market for the Units, Pre-Funded Units, Series L Warrants or Pre-Funded Warrants, and we do not expect a market to develop. In addition,
we do not intend to apply for the listing of the Pre-Funded Warrants or Series L Warrants on any national securities exchange or other
trading market. Without an active trading market, the liquidity of these securities will be limited.

This offering will terminate
on , 2025, unless we decide to terminate the offering (which we may do at any time in
our discretion) prior to such date.

<div align='center'>___________________</div>

We have engaged Maxim Group
LLC as our exclusive placement agent, or Maxim or the placement agent, to use its reasonable best efforts to solicit offers to purchase
our securities in this offering. The placement agent has no obligation to purchase any of the securities from us or to arrange for the
purchase or sale of any specific number or dollar amount of the securities. Because there is no minimum offering amount required as a
condition to closing in this offering the actual public amount, placement agent’s fee, and proceeds to us, if any, are not presently
determinable and may be substantially less than the total maximum offering amounts set forth above and throughout this prospectus. We
have agreed to pay the placement agent the placement agent fees set forth in the table below.

|                                  |     |   | Per  
 Unit |     |   | Per        
 Pre-Funded 
 Unit       |     |   | Total |
|:---------------------------------|:----|:--|:-----|:----|:--|:-----------|:----|:--|:------|
| Public offering price            |     | $ |      |     | $ |            |     | $ |       |
| Placement agent fees(1)          |     | $ |      |     | $ |            |     | $ |       |
| Proceeds, before expenses, to us |     | $ |      |     | $ |            |     | $ |       |

________

| (1) | We will pay the placement agent a cash fee equal to 7.0% of the aggregate gross proceeds raised in this                                     
 offering. In addition, we have agreed to reimburse the placement agent for certain offering-related